Comparing cold and warm water immersion for muscle soreness recovery

Comparative Effectiveness of Cold and Warm Water Immersion in Mitigating Delayed Onset Muscle Soreness: a Multi-Arm Randomized Controlled Trial

Not applicable Interventional Józef Piłsudski University of Physical Education · NCT06804564

This study is testing whether cold or warm water immersion helps young men recover from muscle soreness after exercise better than a control treatment.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment52 (estimated)
Ages18 Years to 25 Years
SexMale
SponsorJózef Piłsudski University of Physical Education Academic / other
Locations1 site (Biała Podlaska, Lublin Voivodeship)
Trial IDNCT06804564 on ClinicalTrials.gov

What this trial studies

This study investigates the effectiveness of cold water immersion (CWI) and warm water immersion (HWI) in alleviating Delayed Onset Muscle Soreness (DOMS) in healthy male participants aged 18-25. It employs a multi-arm, parallel, randomized controlled trial design to compare the physiological and functional outcomes of these interventions following exercise-induced muscle damage. Participants will be randomly assigned to one of three groups: CWI, HWI, or a control group receiving simulated laser therapy, with sessions occurring at specified intervals post-exercise.

Who should consider this trial

Good fit: Ideal candidates for this study are healthy males aged 18-25 who engage in moderate physical activity and experience significant muscle soreness post-exercise.

Not a fit: Patients with inflammatory diseases, neurological disorders affecting muscle strength, or those on certain medications may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide effective recovery strategies for individuals experiencing muscle soreness after intense physical activity.

How similar studies have performed: Other studies have explored various recovery methods for DOMS, but the specific comparison of CWI and HWI in this context is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy males aged 18-25 years
* BMI between 18.5 and 30 kg/m²
* Experiencing muscle pain (VAS scale) \> 5 for muscle soreness within 12 to 30 hours post-exercise
* Engage in moderate physical activity 2-5 hours/week, according to the International Physical Activity Questionnaire-Short Form (IPAQ-SF).
* They must voluntarily sign a written informed consent approved by an ethics/bioethics committee after sufficient explanation prior to participating in the study.

Exclusion Criteria:

* Inflammatory diseases within the past 6 months
* Neurological disorders that affect muscle strength
* Ongoing use of steroids, analgesics, muscle relaxants, or other medications deemed inappropriate by the researchers, including antispasmodics, antidepressants, antidiarrheals, antibiotics, or thrombolytics
* Unstable medical condition such as cardiovascular disease, respiratory disease, gastrointestinal disease, hepatobiliary disease, metabolic disease, endocrine disease, kidney disease, urinary tract disease, genetic disorders, or issues related to the nervous system or mental health.
* Participants who have abused alcohol or drugs in the past year, do not wish to follow the study guidelines, or are deemed inappropriate for the study by the researcher will also be excluded.

Where this trial is running

Biała Podlaska, Lublin Voivodeship

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Muscle Soreness
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.